Company Search:
Advanced Search
Sponsored Links
AcelRx Pharmaceuticals Inc Company Snapshot
AcelRx Pharmaceuticals Inc operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares AcelRx Pharmaceuticals Inc with three other companies in this sector in the United States: Durect Corporation (2015 sales of $19.12 million of which 100% was Pharmaceutical Preparations and Research), Aveo Pharmaceuticals, Incorporation. ($19.02 million of which 100% was Cancer Therapeutics), and Relypsa Inc ($18.55 million of which 100% was Biopharmaceuticals).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
AcelRx Pharmaceuticals Inc
  Stock Performance Chart for AcelRx Pharmaceuticals Inc
  Stock Data: Recent Stock Performance:
  Current Price (1/13/2017): 2.85
(Figures in U.S. Dollars)
1 Week 9.6%   13 Weeks 0.0%  
4 Weeks -14.9%   52 Weeks -10.4%  
AcelRx Pharmaceuticals Inc Key Data:
  Ticker: ACRX Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2015 Sales 19,263,000
(Year Ending Jan 2016).
Employees: 36
  Currency: U.S. Dollars Market Cap: 129,201,302
  Fiscal Yr Ends: December Shares Outstanding: 45,333,790
  Share Type: Common Closely Held Shares: 995,947
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.